UniProt ID | FRIL_HUMAN | |
---|---|---|
UniProt AC | P02792 | |
Protein Name | Ferritin light chain | |
Gene Name | FTL | |
Organism | Homo sapiens (Human). | |
Sequence Length | 175 | |
Subcellular Localization | ||
Protein Description | Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney (By similarity).. | |
Protein Sequence | MSSQIRQNYSTDVEAAVNSLVNLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAEEKREGYERLLKMQNQRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFERLTLKHD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSSQIRQNY ------CCHHHHHHC | 30.83 | 6653779 | |
3 | Phosphorylation | -----MSSQIRQNYS -----CCHHHHHHCH | 28.47 | 24719451 | |
59 | Ubiquitination | FRELAEEKREGYERL HHHHHHHHHHHHHHH | 47.45 | - | |
68 | Ubiquitination | EGYERLLKMQNQRGG HHHHHHHHHHHHHCC | 42.93 | 21906983 | |
83 | Ubiquitination | RALFQDIKKPAEDEW HHCHHHCCCCCCCCC | 62.08 | 83 | |
84 | Ubiquitination | ALFQDIKKPAEDEWG HCHHHCCCCCCCCCC | 50.20 | 21906983 | |
92 | Ubiquitination | PAEDEWGKTPDAMKA CCCCCCCCCHHHHHH | 58.94 | 21906983 | |
98 | Acetylation | GKTPDAMKAAMALEK CCCHHHHHHHHHHHH | 34.41 | 19608861 | |
98 | Ubiquitination | GKTPDAMKAAMALEK CCCHHHHHHHHHHHH | 34.41 | 19608861 | |
105 | Ubiquitination | KAAMALEKKLNQALL HHHHHHHHHHHHHHH | 64.51 | 21906983 | |
106 | Ubiquitination | AAMALEKKLNQALLD HHHHHHHHHHHHHHH | 43.21 | - | |
106 | Malonylation | AAMALEKKLNQALLD HHHHHHHHHHHHHHH | 43.21 | 26320211 | |
119 | Phosphorylation | LDLHALGSARTDPHL HHHHHHCCCCCCHHH | 18.54 | - | |
127 | S-nitrosylation | ARTDPHLCDFLETHF CCCCHHHHHHHHHHC | 2.94 | 22178444 | |
140 | Ubiquitination | HFLDEEVKLIKKMGD HCCHHHHHHHHHHHH | 48.01 | - | |
144 | Ubiquitination | EEVKLIKKMGDHLTN HHHHHHHHHHHHHHH | 40.91 | - | |
150 | Phosphorylation | KKMGDHLTNLHRLGG HHHHHHHHHHHHCCC | 32.11 | 20068231 | |
165 | Phosphorylation | PEAGLGEYLFERLTL CCCCHHHHHHHHHHC | 18.20 | 22817900 | |
173 | Acetylation | LFERLTLKHD----- HHHHHHCCCC----- | 40.26 | 27178108 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FRIL_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FRIL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FRIL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FRIL_HUMAN | FTL | physical | 16189514 | |
M3K12_HUMAN | MAP3K12 | physical | 16169070 | |
TAF10_HUMAN | TAF10 | physical | 16169070 | |
FRIH_HUMAN | FTH1 | physical | 16169070 | |
PTN_HUMAN | PTN | physical | 16169070 | |
FRIL_HUMAN | FTL | physical | 16169070 | |
FRIL_HUMAN | FTL | physical | 20159981 | |
TOX4_HUMAN | TOX4 | physical | 22939629 | |
RPB4_HUMAN | POLR2D | physical | 22939629 | |
IF4G1_HUMAN | EIF4G1 | physical | 22939629 | |
NAMPT_HUMAN | NAMPT | physical | 18486613 | |
C43BP_HUMAN | COL4A3BP | physical | 22863883 | |
PACN2_HUMAN | PACSIN2 | physical | 22863883 | |
FRIL_HUMAN | FTL | physical | 25416956 | |
IMA4_HUMAN | KPNA3 | physical | 25416956 | |
MYOG_HUMAN | MYOG | physical | 25416956 | |
SDCB1_HUMAN | SDCBP | physical | 25416956 | |
USBP1_HUMAN | USHBP1 | physical | 25416956 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
600886 | Hereditary hyperferritinemia-cataract syndrome (HHCS) |
606159 | Neurodegeneration with brain iron accumulation 3 (NBIA3) |
615604 | L-ferritin deficiency (LFTD) |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00893 | Iron Dextran |
loading...
Acetylation | |
Reference | PubMed |
"The amino acid sequence of human liver apoferritin."; Addison J.M., Fitton J.E., Lewis W.G., May K., Harrison P.M.; FEBS Lett. 164:139-144(1983). Cited for: PROTEIN SEQUENCE OF 2-36 AND 41-175. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-98, AND MASS SPECTROMETRY. |